Skip to main content
Watch Insiders
SYRE filings

Corporate insider profile

Cameron Turtle Filing Activity

Latest reported as Chief Executive Officer of Spyre Therapeutics, Inc. (SYRE).

Purchase filings
0
Reported companies
1
Net open-market value
-$4,875,045.00
Latest transaction
Aug 3, 2026

Affiliated corporations

Reported company relationships

SYRELatest reported

Spyre Therapeutics, Inc.

Chief Executive Officer

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Aug 3, 2026Spyre Therapeutics, Inc. (SYRE)Chief Executive OfficerSale15,000$95.51$1,432,706
Jul 1, 2026Spyre Therapeutics, Inc. (SYRE)Chief Executive OfficerSale15,000$87.69$1,315,347
Jun 1, 2026Spyre Therapeutics, Inc. (SYRE)Chief Executive OfficerSale15,000$70.43$1,056,486
🔒 Unlock Real-Time Alerts and 2 More High-Conviction Rows — Subscribe to Watch Insiders Premium